Atabak Mokari

CIK 1678419 · Chief Financial Officer · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.43M

Companies

3

Total Filings

27

Lifetime Open-Market Net

-$2.80M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CORT Chief Financial Officer 16,130 $82.91 $1.34M -$2.80M 20 2026-06-03
BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted Chief Financial Officer $0.07 $0 3 2020-04-09
IRIX CFO and VP Corp Development 81,967 $1.12 $91.8K $0 4 2018-12-13

Recent Filings · Page 2 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-03-05 CORT Mixed +591 $890 EDGAR
2024-02-13 CORT Grant (A) $0 EDGAR
2023-12-05 CORT Grant (A) +1,016 $13.2K EDGAR
2023-09-06 CORT Grant (A) +796 $13.2K EDGAR
2023-06-05 CORT Grant (A) +3,302 $37.9K EDGAR
2023-03-03 CORT Grant (A) +2,520 $25.0K EDGAR
2023-02-15 CORT Grant (A) $0 EDGAR
2022-09-06 CORT Grant (A) +1,586 $20.6K EDGAR
2022-02-11 CORT Grant (A) $0 EDGAR
2021-03-03 CORT Grant (A) $0 EDGAR
Showing 1120 of 27
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.